Boro Dropulić
Impact in
Papers in
- Oncology 54
- CAR-T cell therapy research 54
-
- CRISPR and Genetic Engineering 23
- Viral Infectious Diseases and Gene Expression in Insects 21
- RNA Interference and Gene Delivery 10
- Co-authors
- Rimas J. Orentas (32 shared papers)Dina Schneider (34 shared papers)Laurent Humeau (14 shared papers)Gwendolyn K. Binder (11 shared papers)Vladimir Slepushkin (11 shared papers)Xiaobin Lü (10 shared papers)Kuan-Teh Jeang (2 shared papers)Carl H. June (6 shared papers)
- Journals
- Blood (19 papers)Molecular Therapy (7 papers)Human Gene Therapy (6 papers)Cytotherapy (4 papers)Biology of Blood and Marrow Transplantation (4 papers)
- Partner nations
- United StatesGermanyRussia
In The Last Decade
Boro Dropulić
92 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Virology 574
- Oncology 1.7k
- Genetics 1.3k
- Immunology 639
- Molecular Biology 1.7k
Countries citing papers authored by Boro Dropulić
This map shows the geographic impact of Boro Dropulić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boro Dropulić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boro Dropulić more than expected).
Fields of papers citing papers by Boro Dropulić
This network shows the impact of papers produced by Boro Dropulić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boro Dropulić. The network helps show where Boro Dropulić may publish in the future.
Co-authors
The 25 scholars most cited alongside Boro Dropulić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 361 | |
| 2 | Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial Hit paper breakdown → | 2020 | 318 |
| 3 | 2017 | 203 | |
| 4 | 2015 | 146 | |
| 5 | 2019 | 117 | |
| 6 | 1992 | 108 | |
| 7 | 2005 | 106 | |
| 8 | 2004 | 104 | |
| 9 | 2021 | 100 | |
| 10 | 2017 | 87 | |
| 11 | 2021 | 79 | |
| 12 | 2004 | 76 | |
| 13 | 2005 | 74 | |
| 14 | 1996 | 74 | |
| 15 | 2019 | 72 | |
| 16 | 1993 | 71 | |
| 17 | 2011 | 63 | |
| 18 | 2003 | 63 | |
| 19 | 1994 | 61 | |
| 20 | 2005 | 59 |
About Boro Dropulić
Boro Dropulić is a scholar working on Oncology, Molecular Biology, Genetics, Virology and Immunology, having authored 95 papers that have together received 3.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (54 papers), Virus-based gene therapy research (29 papers), CRISPR and Genetic Engineering (23 papers), Viral Infectious Diseases and Gene Expression in Insects (21 papers), HIV Research and Treatment (18 papers), RNA Interference and Gene Delivery (10 papers), Biosimilars and Bioanalytical Methods (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Virology (574 citations), Oncology (1.7k citations), Genetics (1.3k citations), Immunology (639 citations) and Molecular Biology (1.7k citations). Boro Dropulić has collaborated with scholars based in United States, Germany and Russia. Frequent co-authors include Rimas J. Orentas, Dina Schneider, Laurent Humeau, Gwendolyn K. Binder, Vladimir Slepushkin, Xiaobin Lü, Kuan-Teh Jeang, Carl H. June, Winfried Krueger and Bruce L. Levine. Their work appears in journals such as Blood, Molecular Therapy, Human Gene Therapy, Cytotherapy and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.